General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.
2025 · 2nd Quarter (Apr 1 - June 30)
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CROSSROADS STRATEGIES, LLC
- Filing UUID
- 6c0d5c5b-7633-4b77-80c7-26f1fb878c9e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General education about end stage renal disease (ESRD) and kidney disease policies.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.